Filing Details
- Accession Number:
- 0001562180-23-006858
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-14 17:04:46
- Reporting Period:
- 2023-09-12
- Accepted Time:
- 2023-09-14 17:04:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1412408 | Phreesia Inc. | PHR | Services-Business Services, Nec (7389) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1776729 | David Linetsky | C/O Phreesia, Inc. 1521 Concord Pike, Suite 301 Pmb 221 Wilmington DE 19803 | Svp, Life Sciences | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-12 | 3,279 | $0.00 | 207,320 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2023-09-12 | 475 | $4.71 | 207,795 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-09-12 | 5,689 | $8.03 | 213,484 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-09-12 | 5,689 | $4.71 | 219,173 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-09-12 | 273 | $0.00 | 8,081 | No | 4 | A | Indirect | By spouse |
| Common Stock | Disposition | 2023-09-13 | 1,977 | $20.30 | 217,196 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-09-13 | 82 | $21.20 | 217,114 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-09-13 | 114 | $20.30 | 7,967 | No | 4 | S | Indirect | By spouse |
| Common Stock | Disposition | 2023-09-13 | 5 | $21.20 | 7,962 | No | 4 | S | Indirect | By spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | A | Indirect | By spouse |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By spouse |
| No | 4 | S | Indirect | By spouse |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2023-09-12 | 5,689 | $0.00 | 5,689 | $8.03 |
| Common Stock | Stock Option | Disposition | 2023-09-12 | 475 | $0.00 | 475 | $4.71 |
| Common Stock | Stock Option | Disposition | 2023-09-12 | 5,689 | $0.00 | 5,689 | $4.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-01-16 | No | 4 | M | Direct | |
| 0 | 2028-01-30 | No | 4 | M | Direct | |
| 0 | 2028-08-06 | No | 4 | M | Direct |
Footnotes
- Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the first half of the fiscal year ending January 31, 2024 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $21.27, the closing price of the Issuer's common stock on September 12, 2023.
- Represents RSUs that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's spouse's cash bonus earned for the fiscal first half of the year ending January 31, 2024 under the Issuer's Variable Compensation Plan. The Reporting Person's spouse elected to convert such portion of her earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted is based on a per share value of $21.27, the closing price of the Issuer's common stock on September 12, 2023.
- These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of RSUs.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.11 to $21.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.17 to $21.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This option is fully vested and exercisable as of the date hereof.
Billionaire Hedge Funds
